sodium bisulfide has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albano, E; Bozzola, C; Bruzzì, S; Jindal, A; Locatelli, I; Sutti, S; Vacchiano, M | 1 |
Ding, X; Li, W; Li, Y; Liu, G; Liu, Y; Liu, Z; Pan, Z; Sun, L; Wang, D; Wang, X; Yan, S; Yu, C; Yuan, Y; Yun, F; Zhang, S; Zhao, H; Zhao, J; Zhao, X | 1 |
2 other study(ies) available for sodium bisulfide and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.
Topics: Actins; Animals; Antigens, Differentiation; Antigens, Ly; CD11b Antigen; Choline Deficiency; CX3C Chemokine Receptor 1; Dendritic Cells; Diet; Disease Progression; Flow Cytometry; Gene Expression; Immunohistochemistry; Inflammation; Liver; Methionine; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2015 |
Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway.
Topics: Adult; AMP-Activated Protein Kinases; Animals; Autophagy; Cell Line; Chloroquine; Humans; Hydrogen Sulfide; Hypertriglyceridemia; Hypolipidemic Agents; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; Random Allocation; RNA Interference; Signal Transduction; Sulfides; TOR Serine-Threonine Kinases | 2015 |